Psoriasis Active Not Recruiting Phase 3 Trials for Secukinumab (DB09029)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03478787Risankizumab Versus Secukinumab for Subjects With Moderate to Severe Plaque PsoriasisTreatment